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Background: Ischemic cardiomyopathy induced by myocardial infarction (MI) can cause left ventricular (LV) remodeling resulting in progressive 
dilatation and dysfunction, and has been treated with surgical volume reduction. The purpose of this study was to assess acute reduction in volume 
achieved with a minimally invasive device (BioVentrix, San Ramon, CA) for epicardial catheter-based ventricular reconstruction (ECVR), which enables 
exclusion of the LV scar in an ovine MI model, thereby creating a geometric restoration of the dilated, failing LV. 
Methods: LV anteroapical MI was induced by LAD trans-catheter coil embolization. 60 days later, after scar maturation and establishment of heart 
failure (HF), ECVR, consisting of implantation of a series of anchor pairs to plicate the scarred LV wall, was performed in 11 sheep under fluoroscopic 
and echo guidance. LV performance was evaluated before and immediately after device implantation by echo.
Results: During scar maturation, all animals developed HF characterized by a reduction in LV ejection fraction (EF) and dilated LV chamber. After 
ECVR, LV end-diastolic diameter (EDD), end-diastolic volume (EDV), end-systolic diameter (ESD) and end-systolic volume (ESV) were significantly 
decreased while EF was significantly increased (Data summarized in Table).
Conclusions: ECVR acutely reduces and reshapes the left ventricle, improves LV function and reverses indices of LV remodeling in an MI-induced 
HF ovine model.
EDD (cm) ESD (cm) EDV (ml) ESV (ml) EF%
Baseline 3.85±0.22 2.79±0.21 50.3±8.2 20.4±3.7 59.5±0.2
Pre-device 4.49±0.65* 3.42±0.83* 80.6±23.2* 48.5±18.3* 41.0±6.6*
Post-device 4.00±0.20# 2.86±0.32# 55.9±13.6# 26.1±7.7# 53.8±3.9#*
% Change (post- 
compared to pre-
device)
-9.8±10.1% -13.5±13.9% -26.5±20.7% -41.0±19.4% 12.8±7.0%
Mean ± SD. *P<0.05 vs. baseline; #P<0.05 vs. pre-device.
